Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma

Authors:

Podkonjak T, Cranmer H, Scarisbrick J, McCarthy G, Lilley C and Cheng LI

Publication type:

Journal article

Publication name:

Journal of comparative effectiveness research

Citation:

Podkonjak T, Cranmer H, Scarisbrick J, McCarthy G, Lilley C and Cheng LI. Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma. Journal of comparative effectiveness research. 2021.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies